Toumai

Chronology

Published Mar 8, 2026

Updated Mar 8, 2026

---

CE Mark. 2023.

Remote radical prostatectomy (Shanghai – Hainan). March 2022.

Approval from China’s National Medical Products Administration (NMPA)). Jan, 2022.

Microport founded. 1998.

The Toumai® Surgical Robot, developed by the Chinese company MicroPort MedBot, represents one of the most advanced robotic surgery platforms emerging from China. Development of the system began in the late 2010s as part of MicroPort’s strategy to build a comprehensive portfolio of surgical robots. A major milestone occurred in January 2022, when the Toumai laparoscopic surgical robot received approval from China’s National Medical Products Administration (NMPA) for clinical use, becoming one of the country’s first domestically developed multi-port robotic systems for soft-tissue surgery.

Shortly after regulatory approval, the system demonstrated its capabilities in March 2022, when surgeons used Toumai to perform a robot-assisted radical prostatectomy remotely over a 5G network, operating between Shanghai and Hainan, a distance of nearly 5,000 km—one of the longest telesurgical procedures reported at the time. In the following years, Toumai expanded its clinical adoption within China across urology, general surgery, and gynecology, and in 2023 the system obtained CE marking in Europe, allowing its introduction into selected European centers and marking an important step in MicroPort MedBot’s international expansion in robotic surgery.

Location

Prior to commencing my venture into robotic surgery, I had established a firm grounding as an oncologic surgeon. My experience encompassed a wide range of resection and reconstructive procedures, as well as proficiency in minimally invasive surgical techniques and endoscopic surgery. These acquired skills and expertise serve as fundamental pillars for achieving success in robotic surgery.

---

Disclaimer and Accuracy Statement

All medical information provided on headneckroboticsurgery.com is uploaded and reviewed by a qualified medical doctor with the utmost care and in good faith. The content is accurate, up-to-date, and intended to offer valuable insights for both health professionals and patients. Specific update dates are noted to ensure transparency and relevance.

If you come across any information that you believe to be inaccurate or outdated, please do not hesitate to contact us directly. We are committed to maintaining the highest standards of accuracy and promptly addressing any concerns.